Dominique Grunder

Title: The Innovative Contributions of Dominique Grunder

Introduction

Dominique Grunder is a notable inventor based in Belp, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral treatments. His work has the potential to impact the medical community positively.

Latest Patents

Grunder holds a patent for a pharmaceutical composition containing an antivirally active dihydroquinazoline derivative. This invention relates to pharmaceutical compositions, especially for intravenous administration, which include a specific dihydroquinazoline compound in combination with cyclodextrin excipients, lysine, and arginine. The method for its production and its use in treating illnesses, particularly as an antiviral against cytomegaloviruses, is also covered in this patent. He has 1 patent to his name.

Career Highlights

Throughout his career, Dominique Grunder has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Aicuris GmbH & Co. KG and Aic246 AG & Co. KG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Grunder has collaborated with several professionals in his field, including Kerstin Paulus and Wilfried Schwab. These collaborations have likely enhanced his research and development efforts, leading to advancements in antiviral therapies.

Conclusion

Dominique Grunder's contributions to pharmaceutical innovation, particularly in antiviral treatments, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical science.